Biotech company Novavax to layoff 25% of its employees

Updated : May 10, 2023 16:57
|
Editorji News Desk

Vaccine maker Novavax has announced that the company will layoff 25% of its workforce. The biotech company said that this is done as part of a new restructuring plan. As part of this plan, Novavax will also consolidate its facilities and infrastructure. As per reports, Novavax had around 2,000 employees by the end of 2022. 

"Reducing our workforce has been a difficult decision, but we believe it was necessary to better align our infrastructure and scale to the endemic COVID opportunity," said John C Jacobs, President and Chief Executive Officer, Novavax in a statement. 

The decision to let go employees has come just days after the World Health Organisation, declared Covid is no longer a global health emergency. Global vaccine makers including Moderna and Pfizer are seeing a drop in demand for Covid-19 vaccines. However, Novavax said that it is focussing on updating its Covid vaccine for the fall vaccine season. 

In 2022, Nuvaxovid, Novavax's covid vaccine helped the biotech company to increase its revenue. The company recorded $1.9 billion total revenue, which is 73% more than the revenue recorded in 2021.

Novavax

Recommended For You

editorji | Business

Stock Market Roundup: December 23, 2024 - U.S. Markets Lead, Europe Shows Stability, Asia Gains

editorji | Business

Nifty 50 Stock Analysis – December 23, 2024: Key Losses and Technical Insights

editorji | Business

Top Nifty 50 Gainers on December 23, 2024: Technical Analysis of JSWSTEEL, ITC, HINDALCO, TRENT, and HDFC

editorji | Business

Indian Stock Market stage sharp recovery after five days of fall

editorji | Business

India has potential to be key sustainable aviation fuel producer: IATA